Author

P. R. Dormitzer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2

Frequent Co-Authors

K. A. Swanson· 3 shared A. Muik· 2 shared D. Cooper· 2 shared H. Cai· 2 shared H. Xia· 2 shared J. Zou· 2 shared M. Cutler· 2 shared P.-Y. Shi· 2 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

K. A. Swanson

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants

J. Liu, Y. Liu, H. Xia, J. Zou, S. Weaver, K. A. Swanson, H. Cai, M. Cutler, D. Cooper, A. Muik, K. U. Jansen, U. Sahin, X. Xie, P. R. Dormitzer, P.-Y. Shi

The paper assesses the neutralization ability of BNT162b2-elicited sera against SARS-CoV-2 variants, finding that all sera neutralize variants to titers of ≥80, indicating vaccine effectiveness against emerging strains.

bioRxiv · Sep 13, 2021 · PreprintMicrobiology

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

A. Muik, A.-K. Wallisch, B. Saenger, K. A. Swanson, J. Muehl, W. Chen, H. Cai, R. Sarkar, O. Tuereci, P. R. Dormitzer, U. Sahin

The paper assesses the neutralizing activity of BNT162b2 vaccine-induced sera against SARS-CoV-2 B.1.1.7 pseudoviruses and finds equivalent neutralizing titers compared to the Wuhan strain.

bioRxiv · Jan 18, 2021Immunology

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera

X. Xie, J. Zou, C. R. Fontes-Garfias, H. Xia, K. A. Swanson, M. Cutler, D. Cooper, V. D. Menachery, S. D. Weaver, P. R. Dormitzer, P.-Y. Shi

The paper assesses the neutralizing activity of BNT162b2 vaccine-elicited sera against N501Y and Y501 SARS-CoV-2 variants, finding equivalent neutralizing titers.

bioRxiv · Jan 7, 2021 · PreprintMicrobiology